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Abstract
Skeletal muscle maintenance and repair involve several finely coordinated steps in which pluripotent stem cells are
activated, proliferate, exit the cell cycle and differentiate. This process is accompanied by activation of hundreds of muscle-
specific genes and repression of genes associated with cell proliferation or pluripotency. Mechanisms controlling
myogenesis are precisely coordinated and regulated in time to allow the sequence of activation/inactivation of genes
expression. Muscular differentiation is the result of the interplay between several processes such as transcriptional
induction, transcriptional repression and mRNA stability. mRNA stability is now recognized as an essential mechanism of
control of gene expression. For instance, we previously showed that the endoribonuclease L (RNase L) and its inhibitor (RLI)
regulates MyoD mRNA stability and consequently muscle differentiation. We now performed global gene expression
analysis by SAGE to identify genes that were down-regulated upon activation of RNase L in C2C12 myogenic cells, a model
of satellite cells. We found that RNase L regulates mRNA stability of factors implicated in the control of pluripotency and cell
differentiation. Moreover, inappropriate RNase L expression in C2C12 cells led to inhibition of myogenesis and
differentiation into adipocytes even when cells were grown in conditions permissive for muscle differentiation. Conversely,
over-expression of RLI allowed muscle differentiation of myogenic C2C12 cells even in non permissive conditions. These
findings reveal the central role of RNase L and RLI in controlling gene expression and cell fate during myogenesis. Our data
should provide valuable insights into the mechanisms that control muscle stem cell differentiation and into the mechanism
of metaplasia observed in aging or muscular dystrophy where adipose infiltration of muscle occurs.
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Introduction
Adult skeletal muscle has an exceptional capacity of regener-
ation. Indeed, it is capable of responding to physiological stimuli
for routine maintenance or after a severe injury by complete repair
of the tissue. This feature is due to the presence of satellite cells, a
quiescent population of resident stem cells that are located beneath
the basal lamina and which can generate large quantities of
differentiated muscle cells [1–3]. Furthermore, due to their
capacity to regenerate damaged muscle, satellite cells have been
considered as candidates for cell-based therapies to treat muscular
dystrophies or other muscular diseases characterized by loss of
muscle cells [4].
However, perturbations in muscle cell differentiation can be
observed in vivo in physiological situations, such as aging [5], or in
pathological conditions. For instance, adipose infiltration occurs
during type 2 diabetes and obesity, muscle denervation [6–8] and
in some muscle diseases, such as muscular dystrophy [9] and
mitochondrial myopathy [10]. Several works have demonstrated
that myogenic cells express some adipogenic markers and that,
following specific stimulation, they can differentiate, at least in vitro,
into adipocytes [11,12]. Therefore, myogenic cells can potentially
differentiate both into myoblasts and adipocytes and in some
conditions a change in differentiation program could take place.
Deciphering the molecular mechanisms that control the
proliferation and the possible alternative differentiation pathways
of myogenic cells is, therefore, central to understanding their
function and also is important in view of the use of satellite cells for
therapy. The particular anatomical localization of satellite cells
allows a combination of signals from the muscle fiber itself, the
circulatory system and the extracellular matrix (ECM) to govern
their quiescence, activation and proliferation [13].
Interferon (IFN) is one of the cytokines present in the satellite
cell environment. It is produced by several cell types and also by
muscle cells during skeletal muscle regeneration [14]. The
involvement of IFN and IFN-induced proteins in the regulation
of muscle cell growth and differentiation has been long established
[15–19]. We have previously shown that the IFN-induced 2-5A/
endoribonuclease L (RNase L) and RNase L Inhibitor (RLI), its
inhibitor, play a role in myoblast differentiation by regulating the
stability of MyoD mRNA [20]. IFN induces the expression of 2-5A
synthetase which, upon activation by double stranded RNA,
converts ATP into an unusual series of oligomers known as 2-5A
[21]. 2-5A activate RNase L, a latent endoribonuclease, which
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UpNp sequences.
Our previous work showed that RNase L activity is normally
and transiently induced during myoblast proliferation reaching a
maximum when cells are confluent. Concomitantly, 2-5A
synthetase also is induced allowing RNase L activation [15,22].
RNase L activity is then inhibited by induction of RLI during
induction of muscle-specific genes and cell fusion [20].
In the present work, we wanted to extend our understanding of
the role of RNase L during muscle differentiation. By comparing
global gene expression in C2C12 cells over-expressing RNase L
and in control cells using SAGE (Serial Analysis of Gene
Expression) [23] we identified different transcripts that are
down-regulated by RNase L. Many of these mRNAs encode key
factors implicated in the control of pluripotency, commitment and
differentiation of stem cells. Some of these factors, like Aebp1 or
Chop-10/Ddit3, are implicated in the choice between alternative
differentiation pathways. Moreover, we show that increasing
RNase L expression in C2C12 myogenic cells at an inappropriate
time, such as early during the multipotency phase, favors their
adipogenic potential rather than their myogenic potential.
Conversely, RNase L inhibition by increasing RLI expression
leads to muscle differentiation even in non-permissive culture
medium.
Materials and Methods
Cell culture
For conditional expression of human RNase L, the LacSwitch II
inducible mammalian expression system (Stratagene) was used.
The C2C12 clone in which RNase L is conditionally expressed
(C2-RNase L) was previously described [20]. For induction of
RNase L, C2-RNase L cells were cultured in growth medium
(GM) [DMEM (Cambrex) and 10% (V/V) fetal calf serum (FCS)
(Dutcher)] and at 80% confluence were treated with IPTG
(Isopropyl-b-D-thiogalactopyranoside) as indicated in the figure
legends.
C2-RLI cells, which over-express RLI, were previously
described [20]. These cells were routinely maintained in GM at
low cell density (300 cells/cm
2) [20].
Differentiation of C2-RNase L and C2-RLI cells
For differentiation experiments, C2-RNase L cells were plated at
high density (10
4 cells/cm
2) in GM. When cells reached confluence,
they were switched to differentiation medium. To assess muscle
differentiation, cells were grown in muscle differentiating medium
(MDM) (DMEM supplemented with 2% (V/V) FCS) for 6 days. At
different time points, as indicated in the figure legends, cells were
washed with PBS, fixed in 10% (V/V) formalin for 10 min and
permeabilized with PBS-Triton X100 0.5% (V/V) at room
temperature for 5 minutes. After blocking with 10% (W/V) FCS in
PBS, cells were incubated with a mouse monoclonal anti-Troponin T
antibody (1/1000; Sigma) or a rabbit monoclonal anti-Fabp4/aP2
(1/100; Cell Signaling) at room temperature for 1 h. Cells were then
washed and incubated with a donkey anti-mouse secondary antibody
conjugated to TRITC or FITC (Santa-Cruz) or a donkey anti-rabbit
secondary antibody conjugated to TRITC (Santa-Cruz) at room
temperature for 1 h. For adipocyte differentiation, cellswere cultured
in adipocyte differentiating medium (ADM) [DMEM-10% (V/V)
FCS, 5 mg/ml Bovine insulin (Sigma) and 1 mM dexamethazone
(Sigma)] for 6 days. Lipid cells were visualized by staining with
Oil-red-O [24]. At different time points (see figure legends) cells were
washed twice with PBS, fixed with 10% (V/V) formalin for 15 min,
and then immunostained with an anti Fabp4/aP2 or a rabbit
anti-Perilipin antibody (1/200; Cell signaling) as described above or
stained with 0.3% Oil-red-O (Sigma) in isopropyl alcohol: distilled
water (60:40) at room temperature for 60 min and then washed with
water to remove unbound dye. Lipid accumulation was quantified by
spectrophotometric analysis at 540 nm after eluting the Oil-red-O
retained in the cells with isopropanol [25].
For differentiation experiments, C2-RLI cells were plated at
high density (10
4 cells/cm
2) in GM and, at confluence, they were
switched to ADM as described above. Lipid and muscle cell
phenotypes were characterized as described above.
Analysis of RNase L over-expression
RNase L expression was followed with the 2-5A radio-covalent or
radio-binding assay [26]. C2-RNase L cells, C2C12 cells or C2-RLI
cells were collected, resuspended in 2 volumes of hypotonic buffer
(20 mM HEPES, pH 7.5; 10 mM potassium acetate; 1.5 mM
Magnesium acetate; 1% [vol/vol] NP-40; 1 mM phenylmethylsulfo-
nyl fluoride; 10 mg of aprotinin per ml; 150 mg of leupeptin per ml),
disrupted in a Dounce homogenizer, and centrifuged at 10,0006g
(S10). The protein concentration in the supernatant (S10) was
determined by spectrophotometry [27]. For radiobinding, cell
extracts (600 mg of protein) were incubated with 20,000 cpm of
2-5A4-39-[
32P]pCp (2-5ApCp; 3,000 Ci/mmol) on ice for 15 min as
previously described [28]. Radiolabeled RNase L was then
precipitated at 220uC for 5 min by using 300 ml of polyethylene
glycol 6000 (25% [wt/vol]) after addition of 150 mlo fb o v i n es e r u m
as a carrier.After centrifugation (10,0006g, 10 min), the radioactivity
of the pellet containing the 2-5ApCp bound to RNase L was
measured. Experiments were done in triplicate and the standard
deviation is indicated on the plots. For the radio-covalent assay, cell
extracts (200 mg of protein) were incubated with the oxidized
2-5A4-39-[
32P]pCp probe [28]. Labeled proteins were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) [29] and were visualized by autoradiography. Protein bands
were quantified by image analysis with the Intelligent Quantifier
program (Bio Image Systems Corp.). Experiments were done in
triplicate and the standard deviations are indicated on the plots.
RLI quantification
C2-RLI cells were collected and proteins extracted as described
above. Proteins (100 mg) were fractionated by SDS-PAGE and
transferred electrophoretically to nitrocellulose membranes. Mem-
branes were then blocked with 5% (W/V) skimmed milk in
phosphate-buffered saline (PBS; 140 mM NaCl, 2 mM KCl,
8m MN a 2HPO4, 1.5 mM KH2PO4 [pH 7.4]) for 30 min and
incubated with a rabbit polyclonal anti-RLI antibody (1/500)
(Novus Biological) in the same buffer at 4uC overnight.
Membranes were washed in PBS supplemented with 0.05%
(V/V) Tween 20 and incubated at room temperature with a
donkey anti-rabbit IgG conjugated to horseradish peroxidase
(Amersham) for 1 h. Specific proteins were visualized using a
chemiluminescence kit (Pierce). Films were scanned, and protein
bands quantified by image analysis with the Image J software.
Experiments were done in triplicate and the standard deviation is
indicated on the plots.
rRNA cleavage
C2-RNase L cells were harvested during the proliferative or
multipotency phase after RNase L induction with 5 mM IPTG for
6 hours. Cells were resuspended in 1 volume of buffer (5 mMTris-
HCl pH 7.6; 1.25% (V/V) glycerol; 20 mM KCl; 1.25 mM
magnesium acetate), vortexed for 1 min and kept on ice for
10 min. The cell buffer suspension was passed through a 1-ml
tuberculin syringe and centrifuged at 15,0006g for 2 min. Cell
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presence or absence of 2-5A4 (1 mM, final concentration) for 1 h.
After extraction with TRIzol (Invitrogen) following the manufac-
turer’s instructions and agorose gel analysis, total RNA bands were
visualized under UV light [30].
Construction of SAGE libraries
C2-RNase L cells were seeded at high density in GM. At 80%
confluence cells were treated or not with 5 mM IPTG for 6 hours.
Then, cells were harvested and RNAs extracted with TRIzol
(Invitrogen) following the manufacturer’s instructions. RNA
quality was checked by analysis of total RNA on 1% agarose gel
and visualization of ribosomal bands with ethidium bromide.
80 mg of total RNA from C2-RNase L cells treated with IPTG or
not were used to construct the two SAGE libraries with the I-Sage
kit (Invitrogen) based on the technique developed by Velculescu
[23]. After cloning the concatemers in pZero, the libraries were
electroporated into TOP10 E. Coli competent cells. Transformants
were screened by PCR amplification and inserts .400 nucleotides
(28 tags) were sequenced.
Analysis of SAGE libraries
SAGE libraries were analyzed with the CplusTag and Preditag
software programs developed by Skuld-Tech (Montpellier, France)
[31]. CplusTag was written in C and implemented on a UNIX
operating workstation for automatic tag detection and counting.
This program provided criteria for assessing the quality of the
SAGE libraries (length distribution of ditags, frequency of replicate
ditags, and detection of linkers). Ditags with less than 20 bp were
discarded and repeated ditags were not taken into account for
counting the tag.
Tag prediction. Mm.seq.uniq and Mm.data files were
downloaded from the UniGene FTP site at NCBI (ftp://ncbi.
nlm.nih.gov/repository/UniGene). A table was constructed by
extracting virtual tags from the representative sequences associated
with each UniGene cluster in an Mm.seq.uniq file, then by parsing
attributes associated to each cluster in the Mm.data file. Several
UniGene qualifiers were used directly as column titles, providing
the framework for the main table of the database. An URL was
created for each putative tag, establishing a link with the UniGene
web site. Other fields were created for recording additional data,
including the presence or not of a polyadenylation signal in the
reference sequence, the distance between the anchoring enzyme
site and the end of the sequence, and criteria for evaluating risks of
multiple matches. Full-length cDNAs were distinguished from
ESTs by checking that their sequence was provided by large-scale
sequencing programs (for example, DKFZ). Data were retrieved at
EBI (ftp://ftp.ensembl.org) for the subset of well-annotated genes
(ensembl.cdna). Microsoft Access functions were used for tag-to-
gene assignment and subsequent data management. A query using
the tag sequence as the primary key allowed us to match
experimental sequences (CplusTag), virtual sequences (Preditag)
and selected annotations, thus generating a table of results.
Sequencing of these two libraries allowed the identification of 8367
(Control SAGE) and 7014 (RNase L SAGE) mRNAs and ESTs
which represent 3757 different mRNAs and ESTs expressed one
or more times. A list of the genes, which were .3 fold down-
regulated upon induction of RNase L, is provided in
supplementary Table S1.
Semi-quantitative RT-PCR amplification
Total RNAs were isolated using TRIzol (Invitrogen). To avoid
genomic DNA contamination and amplification during PCR
analysis, RNAs were treated with RNase-free DNase (Euromedex)
before reverse transcription. Complementary DNAs (cDNAs) were
generated by RT with oligo-(dT) primers and the Superscript II
enzyme (Invitrogen). Briefly, 3 mg of total RNA was denatured at
70uC and then reverse-transcribed with Superscript II at 42uC for
50 min. Gene sequences for primer design were obtained from the
NCBI Reference Sequences database. Primers were chosen using
the Primer3 Software except for the forward and reverse EEF1a
primers which were the controls included in the I-Sage kit
(Invitrogen). When possible, the forward and reverse primers for
GAPDH, Aebp1, Ddit3, Stat3, Vimentin, Calponin 2, Nischarin,
RIL, HDAC5, Septin 7, PPARGc2, MyoD, Pax7, Myogenin,
RLI, C/EBPa, aP2, OAS1 (2-5A-synthetase 1) were selected from
different exons sequences. Primer sequences are provided in
supplementary Table S2. PCR amplification (30 cycles) was
performed in a total volume of 25 ml and the amount of each
cDNA was adjusted for each primer pair to be in the linear range
of amplification and to give the same quantity of amplified
complementary DNA as with the EEF1a primers. PCR products
were run in 1.2% agarose gels, stained with ethidium bromide and
bands quantified with the Image J program. Experiments were
done in triplicate and the standard deviations are indicated on the
plots.
mRNA stability
C2-RNase L cells were plated at high density in GM, and, at
80% confluence, RNase L was induced by IPTG (2 mM during
6 h). Then cells were treated with Actinomycin D (5 mg/ml) for 0,
1, 2, 4 or 6 hours and RNAs were extracted and analyzed by semi-
quantitative PCR amplification as described above. Cells were
treated with only 2 mM IPTG to avoid excessive mRNA
degradation by RNase L and to allow mRNA quantification after
Actinomycin D treatment. After agarose gel electrophoresis, gels
were scanned and bands quantified with Image J. Experiments
were done in triplicate and the standard deviations are indicated
on the plots.
Results
Transcriptome analysis
C2C12 cells are myogenic cells that can be used as a model
system to study the early stage of myoblast [32] and adipocyte [33]
differentiation, depending on the cell culture conditions. We have
previously shown that in C2C12 cells, in which an inducible
expression system allows conditional over-expression of RNase L
(C2-RNase L cells) by addition of Isopropyl-b-D-thiogalactopyr-
anoside (IPTG) in the culture medium [20], MyoD was down-
regulated and myogenesis inhibited. To extend our knowledge
about the role of this mRNA degradation pathway in the
commitment of C2C12 cells during differentiation and to identify
mRNAs regulated by RNase L, we have performed global gene
expression analysis using the SAGE (Serial Analysis of Gene
Expression) technology [23] in control C2-RNase L cells (not
treated with IPTG) and C2-RNase L cells over-expressing RNase
L (treated with IPTG).
The nuclease activity of RNase L strictly depends on its
activation by 2-5A, therefore IPTG treatment should be
performed when 2-5A synthetases are present. Others and our
previous work showed that RNase L activity and 2-5A synthetases
(OAS1, 40/46 kDa and OAS2, 69/71 kDa) [21] are normally
transiently induced at the end of the proliferative phase of
myoblasts, during the multipotency period, and reach a maximum
when cells are confluent (Figure 1A) [15,20,22]. For this reason,
we chose to induce RNase L expression in 80% confluent
C2-RNase L cells, i.e., when they can still be committed to
RNase L Regulates Stem Cells
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was monitored by binding to 2-5ApCp (Figure 1A and 1B) and
quantification of the western blots indicated an increase in the
concentration of RNase L compared to control C2-RNase L cells
not treated with IPTG. RNase L induction in the presence of 2-5A
synthetases normally leads to activation of RNase L, as also shown
in Figure 1C. RNase L activity was monitored in vitro by studying
the specific cleavage pattern of rRNA [30]. We could observe
rRNA cleavage even without addition of 2-5A when RNase L was
induced at a time when 2-5A-synthetases are present and active in
the cells (i.e., in 80% confluent cells) (Figure 1C).
On the basis of these preliminary results, cells were harvested
for RNA extraction 6 h after addition of 5 mM IPTG, which
represented the shortest incubation time needed to obtain a good
induction of RNase L without stimulation of apoptosis due to over-
activation of RNase L [34,35]. Then two SAGE libraries were
constructed as previously described [23,31]. To identify RNase L
targets we focused on transcripts that were down-regulated upon
RNase L induction (Supplemental Table S1). Despite its weak
sequence specificity, RNase L induction did not lead to global
RNA decrease, as only 4% (166/3757) of the identified transcripts
were down-regulated more than 3 folds. Functional classification
Figure 1. Scheme of SAGE analysis. A: RNase L expression during myotube differentiation. C2-RNase L cells were plated at high density in
GM (day 1). At day 3 (80% confluence), C2-RNase L cells were treated (-%-) or not (-&-) with 5 mM IPTG for 6 hours and shifted to MDM at confluence
(day 4). At the indicated time points, cells were harvested. To quantify RNase L, proteins (100 mg) were incubated with radio-labeled 2-5A4-39-[
32P]pCp
(2-5ApCp) in a radiocovalent assay; 100% corresponds to the amount of 2-5ApCp bound to RNase L in proliferating myoblasts at day 1. Error bars
refer to the standard deviation obtained in two independent experiments. Gels were scanned and protein bands quantified by image analysis with
the Image J program. Standard deviations are indicated on the plots. RLI expression was assessed in protein samples (100 mg) using an RLI-specific
antiserum. Gels were scanned, and protein bands quantified by image analysis with Image J. The experiments were done in triplicate and standard
deviations are indicated on the plots ( -D-) .B: Induction of RNase L. For SAGE experiments, C2-RNase L cells were treated, or not, with 5 mM IPTG
for 6 hours at day 3 (time indicated with an arrow in panel A). Cells were then harvested and analyzed for RNase L 2-5A binding activity with the 2-5A
radiocovalent binding assay. Proteins were separated in 10% polyacrylamide gels. A representative autoradiography and a densitometry of the gel
are shown. The amount of 2-5A binding activity in C2-RNase L cells in the absence of IPTG was set to 1. Error bars refer to the standard deviation
obtained in three independent experiments. C: Specific RNase L rRNAs cleavage activity. C2-RNase L cells were plated at high density in GM
(day 1). At day 3, cells were treated with 5 mM IPTG for 6 hours. Cells were harvested at day 2 (proliferation) and day 4 (at confluence and after RNase
L induction) and cell extracts (100 mg proteins) were incubated or not (C) at 30uC with 1 mM 2-5A4 for 60 min. After extraction, rRNAs were analyzed
on 0.8% (WT/V) agarose gels. Intact 28S and 18S bands (rRNA from control, untreated cells) are indicated at the left of the gel. Major rRNA
degradation products are indicated by arrows at the right side of the gel. D: Classification by function of the down-regulated genes.
doi:10.1371/journal.pone.0007563.g001
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in different cellular processes and pathways (Figure 1D) which are
important also for the regulation of muscle differentiation. For
instance, among the transcripts involved in cytoskeleton organi-
zation, cell shape and differentiation, we identified Pdlim4/RIL, a
gene down-regulated in H-ras transformed cells [36], which forms
with ALP, Elfin and Mystique the ALP subfamily of PDZ-LIM
proteins [37] and is a regulator of actin stress fiber turnover [38].
Septin 7, a GTP/GDP-binding protein that assemble into
filamentous cytoskeletal polymers, is involved in the organization
of several structures such as the actin stress fibers, cell shape and
signal transduction by sequestering key signaling molecules
[39,40]. Zyxin was the first focal adhesion protein shown to
shuttle between focal adhesion site and nucleus. In the cytoplasm,
Zyxin influences actin assembly and organization as well as cell
motility [41]. Nischarin alters actin filament organization and
inhibits cell motility [42]. Vimentin and Nestin are components of
the intermediate filaments and are expressed in replicating
myoblasts and early myotubes [43,44]. Finally IqSec1 (Brag2/
GEP100), a guanine exchange factor of ADP ribosylation factor 6,
plays a central role in myoblast fusion and myotube maturation
[45].
Another group of transcripts strongly down-regulated by
induction of RNase L encoded for factors which are critical for
maintaining pluripotency in stem cells or for cell fate commitment.
One of these factors, Stat3, plays an essential role in myoblast
proliferation and actively prevents their premature differentiation
[46,47]. Stat3 maintains silencing of differentiation-associated
genes also in self renewing ES cells [48]. The Wnt receptor Fzd7 is
also critical for maintaining pluripotency and self renewal of ES
cells [49,50]. Chop-10/Ddit3, a member of the C/EBP family of
transcription factors, plays a role in cell survival and differentia-
tion, inhibits adipogenesis and induces osteoblastogenesis [51,52].
Aebp1 is a transcriptional repressor that is down-regulated during
adipogenesis [53]. Hdac5, a chromatin-remodeling enzyme,
interacts with MEF2 proteins resulting in repression of MEF2-
dependent genes [54,55]. The H19 locus produces a 2.5-kb non-
coding, spliced and polyadenylated RNA of unknown function
and regulated by imprinting [56]. We have previously shown that
H19 expression is up-regulated exclusively by stabilization of its
RNA during muscle cell differentiation [57]. Recent work
reported that such non coding RNAs have functions in diverse
processes from embryonic stem cell pluripotency to cell prolifer-
ation [58]
RNase L directly regulates master genes that control
pluripotency and cell fate
To experimentally validate the SAGE data, we analyzed by
semi-quantitative RT-PCR amplification the expression level of
some of the identified transcripts, which could be of relevance for
muscle differentiation, and of two negative controls (EEF1 a and
Gapdh) upon induction of different RNase L concentration by
treating, or not, C2-RNase L cells with 2 or 5 mM IPTG for 6 h
(Figure 2). This analysis confirmed that most of these mRNAs
were down-regulated upon induction of RNase L and the intensity
of this effect was proportional to the amount of RNase L induced.
Induction of human RNase L expression both at the mRNA and
protein level was proportional to the IPTG concentration used
(Figure 2A).
As RNase L is an endoribonuclease, if these mRNAs were direct
targets of RNase L, RNase L should regulate their expression at
post-transcriptional level and decrease their half life. Thus, we
quantified their levels in C2-RNase L cells after treatment, or not,
with 2 mM IPTG and Actinomycin D to inhibit transcription
(Figure 3 and Supplemental Table S3). Only the half life of
Calponin 2, Septin 7 and IqSeq1 were not reduced following
RNase L induction in comparison to control cells, suggesting that
all the other transcripts could be directly regulated by RNase L.
These results confirm that RNase L activation in C2C12 myogenic
cells leads to selective mRNA degradation.
Conditional over-expression of RNase L inhibits
myogenesis and favors adipogenesis
Since our data indicate that RNase L regulates master genes
that control pluripotency (Stat3, Fzd7), myogenesis (MyoD, Stat3,
Hdac5) and adipogenesis (Chop-10/Ddit3, Aebp1), we decided to
differentiate C2-RNase L cells after induction of RNase L during
the multipotency phase. To this aim, C2-RNase L cells at 80%
confluency were treated, or not, with 5 mM IPTG for 6 h and
then placed in medium permissive for myotube differentiation
(MDM).
Induction of RNase L expression clearly inhibited myotube
differentiation (Figure 4A). Specifically, in C2-RNase L cells
treated with IPTG, we did not observe cell fusion or expression of
Troponin T, a protein only present in mature myotubes.
Moreover, Myogenin began to be expressed later than in control
cells and at lower level. Pax7 and Msx1, two genes involved in
muscle differentiation, were also down-regulated (Figure 4B).
These results indicate that conditional expression of RNase L
inhibits muscle differentiation of C2C12 myogenic cells.
We then compared the expression of the genes that have been
identified in this work as down-regulated by RNase L during
muscle differentiation in control and IPTG-treated cells. Upon
induction of RNase L, we observed a decrease in the expression of
key regulators of cell fate (Stat3, Aebp1, Chop10/Ddit3, Hdac5,
Fzd7) and also of genes which control cytoskeleton organization,
cell shape, differentiation and signal transduction (Gas1, Nestin,
Nischarin, Zyxin, Vimentin, Calponin 2) (Figure 4B). It must be
noted that down-regulation was observed at day 1 after RNase L
induction, but expression of the different mRNAs was generally
restored at day 5–6 concomitantly with the decrease of RNase L
activity (see Figure 1A) and expression (Figure 4B).
Since induction of RNase L led to concomitant down-regulation
of MyoD, which induces muscle differentiation, and of Aebp1 and
Chop10/Ddit3, which repress adipocyte differentiation [51,59],
we asked whether in the cells treated with IPTG, adipogenesis
would be favored whilst myogenesis was inhibited. Indeed, staining
with Oil red-O, a specific dye for lipids, showed a significant
accumulation of lipids in C2-RNase L cells treated with IPTG
compared to untreated cells, despite being grown in MDM
(Figure 4A, panels g and h). Quantification of lipids by
spectrophotometric analysis at 540 mm after elution of cell-
retained Oil-red-O with isopropanol [25] indicated that C2-
RNase L cells accumulated two times more lipids than untreated
cells (Figure 4C). Adipogenic differentiation is under the control of
several genes, such as the CCAAT/enhancer binding protein-a
(C/EBPa) [60] and peroxisome proliferator activator receptor
gamma 2 (PPARc2) [61], and it is characterized by expression of
some specific proteins like the fatty acid binding protein 4/
adipocyte protein 2 (Fabp4/aP2) [62]. We therefore quantified
their expression in C2-RNase L cells grown in MDM after
treatment, or not, with 5 mM IPTG for 6 h (Figure 4B). C/EBPa
was expressed both in control and RNase L-induced cells but at
different levels; whereas PPARc2 and Fabp4/aP2 were transiently
induced only upon treatment with IPTG (Figure 4B). Expression
of Fabp4/aP2 was also observed at the protein level (Figure 4A,
panels i and j). Moreover, we could confirm that 2-5A-synthetase 1
(OAS1) and 2-5A-synthetase 2 (OAS2) were induced during
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transient induction of RNase L, lipid accumulation was increased
in cells cultured in conditions permissive for muscle differentiation.
However, RNase L activation was not sufficient by itself to induce
complete adipocyte differentiation in MDM, a non permissive
medium for adipocyte differentiation. In addition, treatment of
C2-RNase L cells with 5 mM IPTG for 6 h every two days after
induction of muscle differentiation also did not lead to complete
adipocyte differentiation and induced massive cell death (Supple-
mental Figure S1). In fact, in previous works carried out in several
cell models it was also reported that over-activation of RNase L
stimulated apoptosis [34,35].
We then followed adipocyte differentiation by measuring lipid
accumulation (Figure 5A and 5B), Fabp4/aP2 expression
(Figure 5C), Perilipin expression (Supplemental Figure S3) and
gene expression (Figure 5D) in control and C2-RNase L cells
treated with IPTG in medium permissive for adipocytes
differentiation (ADM). It must be noted that control C2-RNase
L cells displayed a strong adipogenic differentiation even in the
absence of PPAR c activator (Figure 5A and B). Therefore, we
compared adipogenic differentiation in control C2-RNase L cells
and parent C2C12 cells grown in ADM (Supplemental Figure S2).
Quantification of lipids after 6 days of differentiation showed that
control C2-RNase L cells accumulated 25% more lipids than
parent C2C12 cells. This difference could be due the slight
increase in RNase L level observed during the multipotency period
in control C2-RNase L cells in comparison to parent C2C12 cells
even without induction with IPTG (Figure S2, panel C). This
difference could be caused by a leak in the repressor system of the
C2-RNase L cells.
Nevertheless, adipocyte differentiation was accelerated by
RNase L induction: lipid accumulation and Fabp4/aP2 expression
was significantly increased at day 3 of differentiation in RNase
L-induced cells in comparison to control cells (Figure 5A, B and
C). Again, we could observe down-regulation of genes which play
a key role in cell fate commitment, such as Aebp1 and Chop-10/
Ddit3 (Figure 5D). PPARc2 and Fabp4/aP2 mRNA were
expressed early in RNase L-induced cells in comparison to control
cells (Figure 5D).
Since a 6 h treatment with IPTG accelerated adipocyte
differentiation, we asked whether a shorter treatment could be
sufficient. To this aim we incubated C2-RNase L cells with 5 mM
Figure 2. Down-regulation of the identified mRNAs depends on the RNase L level. A: C2-RNase L cells were treated or not with 2 or 5 mM
of IPTG for 6 h. mRNAs were quantified by RT-PCR amplification using specific primers (Supplementary Table S2). PCR products were analyzed on
1.2% agarose gels. Photographs of the gels are shown. Induction of RNase L was also analyzed at the protein level as in Figure 1B. An
autoradiography of the gel is shown (RNase L-P). B: Densitometry of the gels shown in panel A. The level of the different mRNAs in untreated cells
was set at 100%. Quantification of EEF1a mRNAs was used as a control of each semi-quantitative RT-PCR experiment. Error bars refer to the standard
deviation obtained in three independent experiments. (*) P,0.05 and (**) P,0.01 compared to control, untreated cells.
doi:10.1371/journal.pone.0007563.g002
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slightly higher concentration of RNase L protein (Figure 6A) and a
faster adipocyte differentiation than in control cells or cells treated
with IPTG for only 2 hours as shown by C/EBPa, PPARc2,
Fabp4/aP2 mRNA expression and Aebp1 mRNA decrease
(Figure 6B). These results were confirmed also by histological
analysis of Fabp4/aP2 expression (Figure 6C) and quantification
of lipid accumulation (Figure 6D).
Inhibition of RNase L impairs adipocyte differentiation
and favors myocyte differentiation
RNase L activity can be regulated by interaction with RLI which
inhibits its activation by 2-5A [63]. We previously determined that
RLI over-expression in C2C12 cells (C2-RLI cells) accelerates
myotube formation [20] and that in C2-RLI cells RNase L activity is
lower than in control C2C12 cells [20]. Here we show that, in
C2-RLI cells, RNase L activity is 50% lower than in C2-RNase L
cells and 80% lower than in C2-RNase L cells treated with IPTG
(Figure 7A). We thus asked whether inhibition of RNase L activity by
RLI could influence the choice of differentiation pathway of C2C12
cells. To this aim we switched C2-RLI cells to ADM and followed
their differentiation. C2-RLI cells accumulated about 60% fewer
lipids than C2-RNase L cells treated with IPTG (compare Figures 7B,
panels i and j, and 7C with Figures 5B and 6D) and even less than
untreated C2-RNase L cells. Expression of Fabp4/aP2 and of
Perilipin, another adipogenic marker, was low (Figure 7B, panels e
and fand Supplemental Figure S3). Moreover,although C2-RLI cells
were cultured in ADM, we observed formation of myotubes which
expressed Troponin T, a protein specific of mature myotubes
(Figure 7B, panels d and h and Supplemental Figure S3). In these
cells, MyoD and Myogenin were expressed concomitantly with aP2
and PPARc2 (Figure 7D). In addition, Aebp1 and Chop-10/Ddit3
were not down-regulated after induction of adipocyte differentiation
(Figure 7D).
Discussion
Here we report that RNase L and its inhibitor RLI play a
central role in determining muscle cell fate. Myogenesis is
controlled by several functionally coherent mechanisms that are
precisely coordinated and regulated in time to allow the sequence
of activation/inactivation of genes expression. Muscular differen-
Figure 3. Measurement of mRNA stability. C2-RNase L cells were treated with 2 mM IPTG for 6 h and then Actinomycin D (5 mg/ml) was added
to the cell culture medium. Cells were collected at the indicated time points and mRNAs were analyzed by RT-PCR amplification as in Figure 2. PCR
products were then quantified with the Image J program. Error bars refer to the standard deviation obtained in three independent experiments.
doi:10.1371/journal.pone.0007563.g003
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such as transcriptional induction, transcriptional repression and
mRNA stability. mRNA stability is now recognized as an essential
mechanism of control of gene expression [64] and here we show
that its regulation via RNase L is important for muscle
differentiation.
RNase L and RLI are sequentially induced during muscular
differentiation [15,20,22,65] and Figures 1 and 4. Since RNase L is
expressed in a restricted window of time during muscle differentia-
tion, it could play an essential role in regulating the stability of
mRNAs encoding for factors which need to be precisely monitored
during myogenesis. Indeed, we previously showed that RNase L
regulates MyoD mRNA stability [20] and in this work we identified
by SAGE analysis 166 mRNAs which are down-regulated upon
induction of RNase L during the multipotency phase, when C2C12
cells are still proliferating and can differentiate into muscle or adipose
tissues (Table S1 and Figures 1 and 2). Specifically, several factors
controlling muscle stem cell proliferation, cell fate and differentiation,
such as Fzd7, Stat3, IqSec1, Aebp1, Ddit3, Hdac5, H19, were down-
regulated as well as several transcripts implicated in the structure of
actin cytoskeleton (Nischarin), stress fibers (RIL, Septin 7), focal
adhesion (Zyxin), intermediate filaments (Nestin, Vimentin) or in
Ca2+ signaling (Calponin 2). Stress fibers and focal adhesion play a
central role in actin cytoskeleton remodeling during muscle
differentiation. Membrane-cytoskeleton interaction regulates trans-
membrane currents and Ca2+ influx and participates in signal
transduction leading to the regulation of numerous cellular processes
such as gene expression and cell differentiation and in particular cell
fusion [66,67].
Although RNase L has no great sequence specificity [68], its
activation influenced the stability of only a small numbers of
mRNAs (Table S1). Similarly, a limited number of transcripts was
identified following 2-5A transfection of prostate cancer cells [69].
The stability of some mRNAs is determined by AU-rich elements
Figure 4. Induction of RNase L inhibits myotube differentiation and induces lipid accumulation. A: C2-RNase L cells were treated
(+RNase L) or not (Control) with 5 mM IPTG for 6 h at day 0 (panels a and b), and then were induced to differentiate in MDM for 4 (panels c,d,i,j) or 6
days (panels e and f and panels g and h). At the different time points cells were fixed and incubated with a monoclonal antibody against Troponin-T
(panels a to f) or stained with Oil-red-O (panels g and h). At day 4, cells were also analyzed with a monoclonal antibody against Fabp4/aP2 (panels i
and j). Cells were observed at a magnification of 20x, (
__): 60 mm. B: At day 1, C2-RNase L cells were treated (+RNase L) or not (Control) with 5 mM
IPTG for 6 h and then were induced to differentiate in MDM. Cells were then collected at the indicated time points and expression of specific mRNAs
was analyzed by RT-PCR amplification. PCR products were analyzed on 1.2% agarose gels. Photographs of the gels are shown. RNase L protein
expression was analyzed as in Figure 1B. Autoradiographs of these gels are shown (RNase L-P). C: Quantification of lipids accumulated in C2-RNase L
cells treated ( ) or not ( % ) with 5 mM IPTG for 6 h and then induced to differentiate in MDM for 6 days. After staining with Oil-red-O, lipids were
quantified by spectrophotometric analysis at 540 mm following elution of cell-retained Oil-red-O with isopropanol. The amount of lipids in untreated
C2-RNase L cells was set to 1. Data were expressed as mean6SD of three different experimental points. (*) P,0.01 compared to non-induced cells.
doi:10.1371/journal.pone.0007563.g004
RNase L Regulates Stem Cells
PLoS ONE | www.plosone.org 8 October 2009 | Volume 4 | Issue 10 | e7563[70,71]. However, it was not the case for the mRNA identified in
this study. We could not find common nucleic acid motifs among
the identified mRNAs.
Such specificity could be due to interaction of RNase L with
trans-acting factors involved in its recruitment to target RNAs,
such as eRF3 (eukaryotic Release Factor 3) a factor implicated in
mRNA translation [72] and IF2mt (mitochondrial Initiation
Factor 2) a factor implicated in mitochondrial mRNA translation
[35]. In fact, the mRNAs we identified in this work encode factors
expressed during the proliferative and multipotency periods of
myogenic cells. These mRNA are translated when RNase L is
activated. We have previously shown that activation of RNase L
by 2-5A induced its interaction with eRF3 and consequently its
association with the mRNA translation complex [72]. Moreover, it
has been shown that RNase L regulates mRNA stability during
their translation [35,72].
Our results indicate that after RNase L induction muscle cell
fate is modified. RNase L seems to be implicated in the transition
between proliferation and differentiation of myogenic cells.
However, its premature induction led to down-regulation of
MyoD and also of Aebp1 and Chop-10/Ddit3 which inhibit
adipogenesis [51,53]. Normally, their expression is stable during
myogenesis, whereas in IPTG-treated C2-RNase L cells they were
no longer expressed even when cells were induced to differentiate
into muscles. As a consequence, myogenesis was inhibited in favor
of adipogenesis as RNase L-induced cells accumulated more lipids
than control cells and transiently expressed PPARc2 and Fabp4/
aP2 (Figures 4, 5 and 6). However, transient RNase L activation
was not sufficient by itself to induce complete adipocyte
differentiation in MDM, a non permissive medium for adipocyte
differentiation. On the other way, in ADM, RNase L induction
accelerated adipocyte differentiation (Figures 5 and 6), but did not
Figure 5. Increased RNase L levels favor adipocyte differentiation. A: C2-RNase L cells were treated (+RNase L) or not (Control) with 5 mM
IPTG for 6 h at day 0 and then induced to differentiate in ADM. Cells were fixed and stained with Oil-red-O to reveal lipids accumulation at day 0, 3
and 6. Cells were observed at a magnification of 20x, (
__): 60 mm. B: Quantification of lipids in control (%) or IPTG-treated C2-RNase L cells ( ) at day
0, 3 and 6 after induction of differentiation in ADM. After staining with Oil-red-O, lipids were quantified by spectrophotometric analysis at 540 mm
following elution of cell-retained Oil-red-O with isopropanol. The amount of lipids in C2-RNase L cells at T=0, before addition of IPTG, was set to 1.
Error bars refer to the standard deviation obtained in three independent experiments. (*) P,0.01 compared to untreated cells at T=3. C: C2-RNase L
cells were treated (+RNase L) or not (Control) with 5 mM IPTG for 6 h at day 0 and then induced to differentiate in ADM. Cells were fixed at day 0, 3
and 6 and then incubated with an antibody against Fabp4/aP2 (Red). DNA was stained with Dapi (Blue). Cells were observed at 20x, (
__): 50 mm. D:
Analysis of mRNA expression by RT-PCR amplification at different time points during adipocyte differentiation. RNase L was induced (+RNase L) or not
(Control) with 5 mM IPTG for 6 h at day 2 and then cells were switched to ADM to induce adipocyte differentiation. PCR products were analyzed by
gel electrophoresis. Photographs of the gels are shown.
doi:10.1371/journal.pone.0007563.g005
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differentiation as observed in MDM.
As conditional expression of RNase L inhibits myogenesis and
seems to favor adipocyte differentiation, we then inhibited RNase
L by over-expressing RLI, the RNase L inhibitor [63]. Inhibition
of RNase L by RLI prevented down-regulation of Aebp1 and
Chop-10/Ddit3 as well as of MyoD and, as a consequence,
C2C12 cells differentiated into myotubes although they were
grown in a culture medium permissive for adipocyte differentia-
tion. Regulated expression of MyoD [73], Aebp1 [59], PPARc
and Chop-10/Ddit3 [74,75] is crucial for the balance between
myoblast and adipocyte differentiation. Here we show that
deregulated expression of RNase L, an enzyme that controls
mRNA stability of these key factors, can have negative effects on
myogenesis.
Our results show that RNase L seems to be implicated in the
transition between proliferation and differentiation of myogenic
stem cells. Modification in the kinetics of RNase L activation and
inhibition leads to important perturbations in the choice of
differentiation pathway (myogenesis versus adipogenesis) of
C2C12 myogenic cells. Myogenesis is required not only for
normal muscle development, but also for maintenance and repair
of adult myofibers. Impairment in the process of muscle
regeneration has been proposed as one of the important
determinants of skeletal muscle wasting especially in aging and
chronic diseases such as Duchenne muscular dystrophy (DMD). In
these conditions, accumulation of adipose tissue is observed in
skeletal muscle [5,76]. Adipose tissue development is associated
with degenerative/regenerative or atrophic changes in skeletal
muscle fibers and a common feature of these pathologies is a
Figure 6. The kinetics of adipocyte differentiation depends on the RNase L level. A: C2-RNase L cells were treated, or not (0), with 5 mM
IPTG for (2) or (6)h. Cells were then harvested and analyzed for RNase L 2-5A binding activity with the 2-5A radio-covalent binding assay. Proteins
were separated on 10% polyacrylamide gels. A representative autoradiography of the gel and a densitometry of the gel are shown. The amount of 2-
5A binding activity in C2-RNase L cells in the absence of IPTG was set to 1. Error bars refer to the standard deviation obtained in three independent
experiments. (*) P,0.0 compared to non- induced cells (**) P,0.01 compared to control, untreated cells. B: RNase L was induced by 5 mM IPTG for 0,
2 or 6 hours, and then mRNA expression was analyzed by RT-PCR amplification and agarose gel electrophoresis. Photographs and densitometric
analysis of the gels are shown. The level of the different mRNAs in untreated cells was set at 1. Quantification of EEF1a mRNA was used as a control of
semi-quantitative RT-PCR experiment. Error bars refer to the standard deviation obtained in three independent experiments. C: C2-RNase L cells were
treated, or not, with 5 mM IPTG for 2 or 6 h and then induced to differentiate in ADM. At T=0, T=2, T=4 and T=6 days after induction of
differentiation, cells were fixed and stained with Oil-red-O to reveal lipid accumulation (panel on the right) or incubated with an antibody against
Fabp4/aP2 (Red) (panel on the left); DNA was stained with Dapi (Blue). Cells were observed at 20x, (
__): 50 mm. D: Quantification of lipids in control or
IPTG-treated C2-RNase L cells (for 2 or 6 h) at T=0, T=2, T=4 and T=6 days after induction of differentiation with ADM. After staining with Oil-red-O,
lipids were quantified by spectrophotometric analysis at 540 mm following elution of cell-retained Oil-red-O with isopropanol. The amount of lipids
in C2-RNase L cells at T=0, before IPTG treatment, was set to 1. Error bars refer to the standard deviation obtained in three independent experimental
points. (*) P,0.01 compared to untreated cells at the same time during adipocyte differentiation.
doi:10.1371/journal.pone.0007563.g006
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tion, several cytokines are produced continuously not only by
immune cell infiltrates but also by muscle cells [77,78]. Among
these different cytokines IFN is an important regulator of RNase L
[79-82]. If the role of IFN and inflammation has been widely
studied and begins to be understood in human muscle regener-
ation, the role of enzymatic pathways regulated by IFN is still
unknown. In particular, the role of RNase L has not yet been
established in primary myoblasts. Our results show that the level of
RNase L activity could modify muscle cell differentiation and
engage them into adipocyte differentiation. On the other way,
owing to their capacity to regenerate damaged muscle, satellite
cells have been considered as candidates for cell based therapies to
treat muscular dystrophies or other muscular diseases. Under-
standing the role of RNase L/RLI in the control of proliferation
and induction of alternative differentiation pathways in satellite
cells during inflammation is of medical importance and is central
for the development of therapies based on their use.
Supporting Information
Figure S1 C2-RNase L cells were treated with 5 mM IPTG for
6 h at day 0 and then: i) they were induced to differentiate in
MDM (panels a); or ii) they were induced to differentiate in MDM
and were treated again with 5 mM IPTG for 6 h at day 2 (panels
b); or iii) they were induced to differentiate in MDM and were
treated again with 5 mM IPTG for 6 h at day 2 and day 4 (panels
c). At day 6, all the cells were fixed and, stained with Oil-red-O
(panels a, b and c). Cells were observed at 20x, (__): 50 A ˆmm.
Found at: doi:10.1371/journal.pone.0007563.s001 (1.17 MB TIF)
Figure S2 A: C2C12 and C2-RNase L cells were plated at high
density in GM and shifted to ADM at confluence. At day 6, cells
were fixed and stained with Oil-red-O. Cells were observed at
20x, (__): 50 A ˆ mm. B: Quantification of lipids in differentiated
C2C12 and C2-RNase L cells at day 6 after induction of
differentiation with ADM. A value of 1 corresponds to the
amount of lipids in C2C12 cells at day 6. Error bars refer to the
standard deviation obtained in three independent experimental
p o i n t s .C :R N a s eLb i n d i n gt o2 - 5 A .C 2 C 1 2a n dC 2 - R N a s eL
cells wereplatedathighdensityi nG M( da y1) .Atda y3(i . e. ,8 0 %
confluence, multipotency period), cells were harvested and
analyzed for RNase L binding to 2-5A with the 2-5A radio-
covalent binding assay. Proteins were separated on 10%
polyacrylamide gels. A representative autoradiography and a
densitometry of the gel are shown.
Figure 7. Inhibition of adipocyte differentiation by RLI. A: RNase L activity in C2-RNase L cells, C2-RNase L cells treated with IPTG
and C2-RLI cells. C2-RLI cells (1,%), C2-RNase L cells (2, ) and C2-RNase L treated with 5 mM IPTG (3, ) for 6 h were analyzed for RNase L 2-5A
binding activity with the 2-5A radiocovalent binding assay. Proteins were separated in 10% polyacrylamide gels. A representative autoradiography
and a densitometry of the gel are shown. The amount of 2-5A binding activity in C2-RLI cells was set to 1. Error bars refer to the standard deviation
obtained in three independent experiments. B: C2-RLI differentiation. Cells were fixed and incubated with Oil-red-O to reveal lipid accumulation
(i=day 0, j=day 6 after induction of differentiation with ADM) and expression of Troponin T and Fabp4/aP2 was analyzed using monoclonal
antibodies against Troponin T (Green, c,d) and Fabp4/aP2 (Red e,f) at day 0 (a,c,e,g,i) and day 6 after induction of differentiation with ADM (b,d,f,h,j).
DNA was stained with Dapi (Blue a,b,g,h). A merge of Dapi, Troponin T and Fabp4/aP2 labeling is shown (g,h). Cells were observed at 20x, (
__): 20 mm.
C: Quantification of lipids in C2-RLI cells at day 0 (%) and day 6 after induction of differentiation with ADM ( ). A value of 1 corresponds to the
amount of lipids in C2-RLI cells at T=0, before differentiation. After staining with Oil-red-O, lipids were quantified by spectrophotometric analysis at
540 mm following elution of cell-retained Oil-red-O with isopropanol. Error bars refer to the standard deviation obtained in three independent
experiments. (*) P,0.01 compared to untreated C2-RNase L cells and (**) P,0.01 compared to IPTG-treated C2-RNase L cells at the same time point
during adipocyte differentiation. D: Analysis of mRNA expression by RT-PCR amplification at different time points during adipocyte differentiation.
C2-RLI cells were switched to ADM to induce adipocyte differentiation at day 1. PCR products were analyzed by gel electrophoresis. Photographs of
the gels are shown.
doi:10.1371/journal.pone.0007563.g007
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Figure S3 C2-RNase L cells (a), C2-RNase L cells treated with
IPTG 5 mM for 6 h (b) and C2-RLI cells were plated at high
density in GM and shifted to ADM at confluence. At day 6, cells
were fixed and expression of Perilipin (red) and Troponin T
(green) was analyzed using antibodies. DNA was stained with
Dapi (Blue). A merge of Dapi, Troponin T and Perilipin labeling
is shown. Cells were observed at 20x, (__): 20 mm.
Found at: doi:10.1371/journal.pone.0007563.s003 (3.50 MB TIF)
Table S1 Down-regulated genes. List of the 166 genes that were
down-regulated more than three folds in C2-RNase L cells after
RNase L induction and their level in control C2-RNase L cells.
Found at: doi:10.1371/journal.pone.0007563.s004 (0.16 MB
XLS)
Table S2 PCR primers used to study the expression of the
different transcripts
Found at: doi:10.1371/journal.pone.0007563.s005 (0.02 MB
XLS)
Table S3 Half life of mRNAs down-regulated upon RNase L
induction. Half lives were calculated by non linear regression
analysis of the percentage of mRNA remaining as a function of
time after Actinomycin D treatment of C2-RNase L cells
incubated or not with 2 mM IPTG for 6 hours. Data are the
mean of three independent experiments.
Found at: doi:10.1371/journal.pone.0007563.s006 (0.04 MB
RTF)
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